Asia-pacific Pharmaceutical Supply Chain Management Market Forecast 2023-2032

The Asia-Pacific pharmaceutical supply chain management market is evaluated to register a CAGR of 9.01% during the estimated period of 2023-2032. The market growth of the region is attributable to the rapidly developing pharmaceutical sector in the Asia-Pacific, as well as the increased Internet and mobile device adoption.

MARKET INSIGHTS

The Asia-Pacific pharmaceutical supply chain management market growth assessment constitutes the analysis of India, South Korea, Australia & New Zealand, China, Japan, and Rest of Asia-Pacific. As the region continues to strengthen its foothold in the medical device industry, tremendous growth is expected over the upcoming years. Aligning with this, as per the Ministry of Food and Drug Safety (MFDS), the medical device segment in South Korea has doubled in size since 2010. Furthermore, the high demand for pharmaceuticals in the country is majorly accredited to the surging population as well as the rising incidence of chronic diseases.

Conversely, with the development and adoption of various technologies in South Korea's healthcare industry, including 3D printing technology for cardiovascular devices, the nation has observed a significant surge in demand for highly advanced medical products. As a result, the need for strong pharma supply chain management (SCM), coupled with the increasing demand for drugs, is projected to fuel the Asia-Pacific pharmaceutical supply chain management market growth over the projection period.

COMPETITIVE INSIGHTS

Key companies operating in the market are: Manhattan Associates Inc, Cardinal Health Inc, SAP SE, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51608

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
- 3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
- 3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
- 3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
- 3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING IN THE PHARMA INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
- 3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
- 3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
- 3.2.4. SECURITY ISSUES IN WEAK SCM LINKS

4. KEY ANALYTICS

4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET CONCENTRATION ANALYSIS
4.5. MARKET MATURITY ANALYSIS

5. MARKET BY COMPONENT

5.1. SOLUTION
- 5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
- 5.1.2. PLANNING & ANALYTICS
- 5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
- 5.1.4. PROCUREMENT & SOURCING
- 5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
- 5.2.1. PROFESSIONAL SERVICES
- 5.2.2. MANAGED SERVICES

6. MARKET BY DEPLOYMENT MODE

6.1. ON-PREMISE
6.2. CLOUD-BASED

7. GEOGRAPHICAL ANALYSIS

7.1. ASIA-PACIFIC
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
- 7.1.3. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
- 7.1.4. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
- 7.1.5. KEY PLAYERS IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
- 7.1.6. COUNTRY ANALYSIS
  - 7.1.6.1. CHINA
  - 7.1.6.1.1. CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.2. JAPAN
  - 7.1.6.2.1. JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.3. INDIA
  - 7.1.6.3.1. INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.4. SOUTH KOREA
  - 7.1.6.4.1. SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.5. AUSTRALIA & NEW ZEALAND
  - 7.1.6.5.1. AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.6. REST OF ASIA-PACIFIC
  - 7.1.6.6.1. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. PRODUCT LAUNCHES
- 8.1.2. PARTNERSHIPS
8.2. COMPANY PROFILES
- 8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. CARDINAL HEALTH
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
  - 8.2.2.3. STRENGTHS & CHALLENGES
- 8.2.3. EPICOR SOFTWARE CORPORATION
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
- 8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. INFOR
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
  - 8.2.5.3. STRENGTHS & CHALLENGES
- 8.2.6. JUMP TECHNOLOGIES
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
- 8.2.7. LOGITAG SYSTEMS
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
- 8.2.8. MANHATTAN ASSOCIATES
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. MCKESSON CORPORATION
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
  - 8.2.9.3. STRENGTHS & CHALLENGES
- 8.2.10. ORACLE CORPORATION
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SAP SE
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SPECTRUM HEALTH
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. TECSYS INC
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
  - 8.2.13.3. STRENGTHS & CHALLENGES
- 8.2.14. TERSO SOLUTION
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. VIZIENT INC
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST

Product Code: 51608

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 3: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: KEY PLAYERS OPERATING IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
TABLE 14: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
TABLE 15: LIST OF PRODUCT LAUNCHES
TABLE 16: LIST OF PARTNERSHIPS

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 7: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2032 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022
FIGURE 9: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2032 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2032 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022
FIGURE 16: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022
FIGURE 19: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2032 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2032 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 22: CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)